Spotswood, NJ, United States of America

Laura Edgerly-Pflug

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: The Liposome Company, Inc.. Active years: 1996.


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Laura Edgerly-Pflug: Innovator in Liposome Technology

Introduction

Laura Edgerly-Pflug is a notable inventor based in Spotswood, NJ (US). She has made significant contributions to the field of liposome technology, which has important applications in drug delivery systems. Her innovative approach has led to the development of a unique method for producing liposomes.

Latest Patents

Laura holds a patent for a "Method of producing liposomes." This invention provides a process for the production of liposomes by combining an organic phase and an aqueous phase at a volume ratio of less than 3:1. The process can be conducted under conditions that achieve a single-modal population distribution of liposomes, encompassing a pre-selected mean particle size. Additionally, a novel intermediate product obtained during the process can be used for the topical delivery of a bioactive agent.

Career Highlights

Laura is currently associated with The Liposome Company, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in enhancing the efficacy of liposomal formulations, which are crucial for various therapeutic applications.

Collaborations

Laura has collaborated with esteemed colleagues, including Royden M Coe and Joel B Portnoff. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Laura Edgerly-Pflug is a pioneering inventor whose work in liposome technology has the potential to revolutionize drug delivery systems. Her contributions are significant in the field, and her innovative methods continue to inspire advancements in pharmaceutical research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…